Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B S Kramer

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
International Journal of Cancer|July 15, 1990
Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human lung cancer cell linesC M Tsai, A F Gazdar, C Allegra, et al.
Biochemical and Biophysical Research Communications|September 23, 1974
Decomposition of BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) in aqueous solutionM Colvin, J W Cowens, R B Brundrett, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1983
Early results of a comparative trial of ceftazidime versus cephalothin, carbenicillin and gentamicin in the treatment of febrile granulocytopenic patientsR Ramphal, B S Kramer, K H Rand, et al.
Journal of Virology|April 1, 1978
Biochemical characterization of the amphotropic group of murine leukemia virusesS K Chattopadhyay, J W Hartley, M R Lander, et al.
Journal of the National Cancer Institute|October 16, 1991
Potential role of tamoxifen in prevention of breast cancerS G Nayfield, J E Karp, L G Ford, et al.
Journal of the National Cancer Institute|December 31, 1997
Tobacco addiction: implications for treatment and cancer preventionP M Cinciripini, S S Hecht, J E Henningfield, et al.
Journal of the National Cancer Institute|February 7, 1990
Chemosensitivity patterns and expression of human multidrug resistance-associated MDR1 gene by human gastric and colorectal carcinoma cell linesJ G Park, B S Kramer, S L Lai, et al.
Cancer Treatment Reports|October 1, 1977
Treatment of refractory acute leukemia with high-dose chemotherapyB S Kramer, F R Appelbaum, G P Herzig, et al.
Cancer Causes & Control : CCC|February 6, 1999
The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United StatesJ M Legler, E J Feuer, A L Potosky, et al.
Annals of Internal Medicine|November 1, 1993
Prostate cancer screening: what we know and what we need to knowB S Kramer, M L Brown, P C Prorok, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
International Journal of Cancer|July 15, 1990
Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human lung cancer cell linesC M Tsai, A F Gazdar, C Allegra, et al.
Biochemical and Biophysical Research Communications|September 23, 1974
Decomposition of BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) in aqueous solutionM Colvin, J W Cowens, R B Brundrett, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1983
Early results of a comparative trial of ceftazidime versus cephalothin, carbenicillin and gentamicin in the treatment of febrile granulocytopenic patientsR Ramphal, B S Kramer, K H Rand, et al.
Journal of Virology|April 1, 1978
Biochemical characterization of the amphotropic group of murine leukemia virusesS K Chattopadhyay, J W Hartley, M R Lander, et al.
Journal of the National Cancer Institute|October 16, 1991
Potential role of tamoxifen in prevention of breast cancerS G Nayfield, J E Karp, L G Ford, et al.
Journal of the National Cancer Institute|December 31, 1997
Tobacco addiction: implications for treatment and cancer preventionP M Cinciripini, S S Hecht, J E Henningfield, et al.
Journal of the National Cancer Institute|February 7, 1990
Chemosensitivity patterns and expression of human multidrug resistance-associated MDR1 gene by human gastric and colorectal carcinoma cell linesJ G Park, B S Kramer, S L Lai, et al.
Cancer Treatment Reports|October 1, 1977
Treatment of refractory acute leukemia with high-dose chemotherapyB S Kramer, F R Appelbaum, G P Herzig, et al.
Cancer Causes & Control : CCC|February 6, 1999
The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United StatesJ M Legler, E J Feuer, A L Potosky, et al.
Annals of Internal Medicine|November 1, 1993
Prostate cancer screening: what we know and what we need to knowB S Kramer, M L Brown, P C Prorok, et al.
Pageof 9